NASDAQ:SNES - SenesTech Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SenesTech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.59 -0.01 (-1.68 %) (As of 12/9/2019 06:00 AM ET) Add Compare Today's Range$0.58Now: $0.59▼$0.6350-Day Range$0.58MA: $0.69▼$0.8352-Week Range$0.55Now: $0.59▼$1.95Volume65,764 shsAverage Volume97,522 shsMarket Capitalization$16.56 millionP/E RatioN/ADividend YieldN/ABeta1.73 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SNES Previous Symbol CUSIPN/A CIK1680378 Webhttp://www.senestech.com/ Phone928-779-4143Debt Debt-to-Equity Ratio0.04 Current Ratio4.73 Quick Ratio3.66Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$300,000.00 Price / Sales55.18 Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book2.17Profitability EPS (Most Recent Fiscal Year)($0.63) Net Income$-11,910,000.00 Net Margins-4,568.52% Return on Equity-200.80% Return on Assets-154.63%Miscellaneous Employees40 Outstanding Shares28,290,000Market Cap$16.56 million Next Earnings Date3/26/2020 (Estimated) OptionableNot Optionable Receive SNES News and Ratings via Email Sign-up to receive the latest news and ratings for SNES and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:SNES Rates by TradingView SenesTech (NASDAQ:SNES) Frequently Asked Questions What is SenesTech's stock symbol? SenesTech trades on the NASDAQ under the ticker symbol "SNES." How were SenesTech's earnings last quarter? SenesTech Inc (NASDAQ:SNES) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.09) earnings per share (EPS) for the quarter. The firm had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.04 million. SenesTech had a negative return on equity of 200.80% and a negative net margin of 4,568.52%. View SenesTech's Earnings History. When is SenesTech's next earnings date? SenesTech is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for SenesTech. Has SenesTech been receiving favorable news coverage? News stories about SNES stock have been trending somewhat negative on Monday, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SenesTech earned a news impact score of -1.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for SenesTech. Who are some of SenesTech's key competitors? Some companies that are related to SenesTech include Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), China Green Agriculture (CGA), Eden Research (EDEN), Bion Environmental Technologies (BNET), Kiwa Bio-Tech Products Group (KWBT) and Cavitation Technologies (CVAT). What other stocks do shareholders of SenesTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Marathon Oil (MRO), Auris Medical (EARS), Histogenics (HSGX), McDermott International (MDR), Melinta Therapeutics (MLNT), ZIOPHARM Oncology (ZIOP), Adamis Pharmaceuticals (ADMP) and Catabasis Pharmaceuticals (CATB). Who are SenesTech's key executives? SenesTech's management team includes the folowing people: Dr. Loretta Powers Mayer, Co-Founder, Chair of the Board, CEO & Chief Scientific Officer (Age 70)Dr. Cheryl Ann Dyer, Co-Founder, Pres & Chief Research Officer (Age 67)Mr. Thomas C. Chesterman, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 60)Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 64)Mr. Joe Malinowski, VP of Sales When did SenesTech IPO? (SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager. Who are SenesTech's major shareholders? SenesTech's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Sabby Management LLC (0.17%). Company insiders that own SenesTech stock include Cheryl Ann Dyer, Julia Ann Williams, Kenneth S Siegel and Loretta Powers Mayer. View Institutional Ownership Trends for SenesTech. Which major investors are buying SenesTech stock? SNES stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC. Company insiders that have bought SenesTech stock in the last two years include Julia Ann Williams and Kenneth S Siegel. View Insider Buying and Selling for SenesTech. How do I buy shares of SenesTech? Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is SenesTech's stock price today? One share of SNES stock can currently be purchased for approximately $0.59. How big of a company is SenesTech? SenesTech has a market capitalization of $16.56 million and generates $300,000.00 in revenue each year. The company earns $-11,910,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis. SenesTech employs 40 workers across the globe.View Additional Information About SenesTech. What is SenesTech's official website? The official website for SenesTech is http://www.senestech.com/. How can I contact SenesTech? SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected] MarketBeat Community Rating for SenesTech (NASDAQ SNES)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 289 (Vote Outperform)Underperform Votes: 300 (Vote Underperform)Total Votes: 589MarketBeat's community ratings are surveys of what our community members think about SenesTech and other stocks. Vote "Outperform" if you believe SNES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNES will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2019 by MarketBeat.com StaffFeatured Article: What are gap-down stocks?
